ALDH1A3 may promote progress and metastasis of various cancers, such as prostate cancer [34], gallbladder cancer [35], breast cancer [36], ovarian cancer [37] and NSCLC [38], as well as gastric cancer in our study, and be identified as the biomarkers for poor prognosis. Here, ALDH1A3 is linked to ovarian carcinoma.